844 related articles for article (PubMed ID: 5785756)
1. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
Raby C
Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
[No Abstract] [Full Text] [Related]
2. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
Migne J; Monteil R; Pessereau G; Pernod J; Siau J
Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
[No Abstract] [Full Text] [Related]
3. [Effect of various laboratory tests in the control of anticoagulant therapy].
Molinas FC; Sanchez Avalos JC
Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
[No Abstract] [Full Text] [Related]
4. [Role of liver maintenance of normal hemostasis].
Rosiek B
Pol Tyg Lek; 1974 Jun; 30(22):949-52. PubMed ID: 4601065
[No Abstract] [Full Text] [Related]
5. [Vitamin K dependent blood clotting proteins (author's transl)].
Kopeć M
Postepy Biochem; 1980; 26(1):3-28. PubMed ID: 6994082
[No Abstract] [Full Text] [Related]
6. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
Satake K
Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
[No Abstract] [Full Text] [Related]
7. Vitamin K--dependent clotting factors.
Prydz H
Semin Thromb Hemost; 1977; 4(1):1-14. PubMed ID: 335512
[No Abstract] [Full Text] [Related]
8. [The liver and plasma coagulation factors. Physiology].
Róka L
Thromb Diath Haemorrh Suppl; 1973; 55():5-36. PubMed ID: 4612867
[No Abstract] [Full Text] [Related]
9. Mechanism of action and monitoring of anticoagulants.
Hirsh J
Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
[No Abstract] [Full Text] [Related]
10. Recent advances in the control of anticoagulant therapy.
Owren PA
Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
[No Abstract] [Full Text] [Related]
11. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
Xi M; Béguin S; Hemker HC
Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
[TBL] [Abstract][Full Text] [Related]
12. [Principles, limits, and modalities of application of classical anticoagulants].
Vergoz D
Phlebologie; 1973; 26(1):105-7. PubMed ID: 4724444
[No Abstract] [Full Text] [Related]
13. [Pharmacology of oral anticoagulants].
Richter M; Markwardt F
Z Gesamte Inn Med; 1979 Jan; 34(1):8-17. PubMed ID: 433362
[TBL] [Abstract][Full Text] [Related]
14. [Physiological and physiopathological bases for a rational anticoagulant therapy].
Raby C
J Sci Med Lille; 1968 Nov; 86(11):659-94. PubMed ID: 5701301
[No Abstract] [Full Text] [Related]
15. Hemostasis in surgical procedures.
Quick AJ
Surg Gynecol Obstet; 1969 Mar; 128(3):523-32. PubMed ID: 4180878
[No Abstract] [Full Text] [Related]
16. Anticoagulants.
Forbes CD; Prentice CR
Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
[No Abstract] [Full Text] [Related]
17. The liver and blood coagulation: physiology and pathology.
Roberts HR; Cederbaum AI
Gastroenterology; 1972 Aug; 63(2):297-320. PubMed ID: 4558715
[No Abstract] [Full Text] [Related]
18. Vitamin K and warfarin. Metabolism, function and interaction.
Woolf IL; Babior BM
Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
[No Abstract] [Full Text] [Related]
19. Warfarin therapy. 1.
Deykin D
N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
[No Abstract] [Full Text] [Related]
20. [Action of vitreous body in the blood coagulation].
Regnault F; Larrieu MJ
Pathol Biol (Paris); 1969 Jan; 17(1):31-7. PubMed ID: 4895968
[No Abstract] [Full Text] [Related]
[Next] [New Search]
